Physician

Michael C Coan, D.O.

According to 2025 Medicare claims, Michael Coan, D.O. (NPI: 1386955904) practices internal medicine in the Spokane-Spokane Valley, WA market, with the plurality of this provider's patient population coming from Spokane, WA. This provider's primary affiliated billing organization is ARTHRITIS NORTHWEST PLLC (NPI: 1558408104; TIN: 912152662) and primary practice location at 99216-1061. Coan is affiliated with the Kootenai Accountable Care, LLC (ACO ID: A3621), MultiCare Connected Care, LLC (ACO ID: A3631), Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), PSW ACO (ACO ID: A5323), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Coan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 566 traditional Medicare patients, billed 79,812 HCPCS/CPT codes, and received $994,840 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,177 prescription claims across 455 beneficiaries totaling $2,318,976 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 98 records totaling $47,901. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $66,398 to $994,840. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,405,531 and ending at $2,318,976. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	251	2,960	$66,398
2016	232	1,039	$27,363
2017	220	500	$32,515
2018	306	842	$48,549
2019	311	8,686	$326,040
2020	346	14,209	$359,349
2021	548	61,603	$1,200,446
2022	545	74,806	$1,119,631
2023	544	77,757	$1,013,296
2024	566	79,812	$994,840

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	264	2,372	$1,405,531
2016	253	1,321	$952,852
2017	174	945	$482,659
2018	221	1,552	$1,229,469
2019	197	1,163	$1,004,890
2020	199	1,278	$763,145
2021	302	1,554	$975,353
2022	378	2,034	$1,427,996
2023	372	1,901	$1,593,193
2024	455	2,177	$2,318,976

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	420	638	$89
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	379	542	$13
36415	Insertion of needle into vein for collection of blood sample	281	463	$9
86140	Measurement c-reactive protein for detection of infection or inflammation	301	601	$5
85652	Red blood cell sedimentation rate, to detect inflammation, automated	297	575	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	109	3,276	$817,762
Enbrel	Etanercept	43	1,204	$300,242
Ofev	Nintedanib Esylate	13	390	$156,824
Otezla	Apremilast	25	930	$152,791
Humira Pen	Adalimumab	16	448	$104,730

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	96	$2,028	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$45,873	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael C. Coan, D.O.?

Tedicare shows public-source Medicare data for Michael C. Coan, D.O. (NPI 1386955904), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael C. Coan, D.O. have ACO affiliation data?

Michael C. Coan, D.O. is shown with ACO affiliation data for Kootenai Accountable Care, LLC (MSSP, ACO ID A3621), MultiCare Connected Care, LLC (MSSP, ACO ID A3631), Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), PSW ACO (MSSP, ACO ID A5323), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Michael C. Coan, D.O.?

Michael C. Coan, D.O. is linked to ARTHRITIS NORTHWEST PLLC (billing NPI 1558408104) in the available physician profile data.

Does Michael C. Coan, D.O. have Open Payments data?

Michael C. Coan, D.O. has 98 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.